N-Carbobenzoxy-4-hydroxy-D-2-phenylglycine>98.0%(HPLC)(T)5g

(R)-3-Hydroxypiperidin-2-one, 95+%, 250mg

(R)-methyl pyrrolidine-3-carboxylate hydrochloride, 95.0%, 250mg

(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride, 95%, 25g

2,6-Dibromo-4-fluoroaniline, 98.0%, 25g

1,2,3,4-Tetrahydronaphthalene>97.0%(GC)500mL

((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane, 97%, 5g

n-Ethyl-6-methylpyridazin-3-amine, 97%, 500mg

4-Bromo-5-fluoro-1-methylpyridin-2(1H)-one, 97%, 25mg

tert-butyl 3-{[2-(pyrrolidin-1-yl)ethyl]amino}propanoate, 95.0%, 2g

3,5-Dichlorobenzoic Acid>98.0%(T)25g

1-(1,4-diazepan-1-yl)-3,5,5-trimethylhexan-1-one, 95.0%, 2g

2-amino-5-(2-methoxyphenoxy)benzoic acid, 95.0%, 250mg